mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
PDF) Generating an Anti-HIV Vaccine Using Nucleoside-modified mRNA Encoding Envelope
PDF) mRNA vaccines — a new era in vaccinology
Moderna's coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities - The Washington Post
Moncef Slaoui - Wikipedia
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
mRNA vaccines - a new era in vaccinology. - Abstract - Europe PMC
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Michael J. Hogan's research works | The Children's Hospital of Philadelphia, PA (CHOP) and other places
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery - ScienceDirect
Crowd fund launched for 'Battlestar Galactica' actor Michael Hogan after brain injury
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
Moderna's coronavirus vaccine shows encouraging early results - The Washington Post
